{"id":"NCT00704379","sponsor":"Baylor College of Medicine","briefTitle":"Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury","officialTitle":"Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2008-06","primaryCompletion":"2014-04","completion":"2014-04","firstPosted":"2008-06-24","resultsPosted":"2015-05-12","lastUpdate":"2015-08-25"},"enrollment":94,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Traumatic Brain Injury"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Sertraline","otherNames":["Zoloft"]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Sertraline","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to examine the efficacy of sertraline to prevent the onset of mood and anxiety disorders during the first six months after traumatic brain injury.","primaryOutcome":{"measure":"Time to Onset of Diagnostic and Statistical Manual (DSM) IV Defined Mood and Anxiety Disorders Associated With Traumatic Brain Injury (TBI)","timeFrame":"6 months after TBI","effectByArm":[{"arm":"Placebo","deltaMin":21.4264,"sd":0.9982},{"arm":"Sertraline","deltaMin":15.7833,"sd":0.2091}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.05"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":8},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["11096746","14706944","2404002","14706943","11001601","10952055","9775390","16362181","12706957","16425236","16631126","12907793","17240361","11704071","15856081","15808493","15037457","16084738","12547979","8426177","8428134","8509524","8286933","7931619","8494069","15276953","16304485","15616168","27626622"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":46},"commonTop":["Diarrhea","Dizziness","Lightheadedness","Dry mouth","Insomnia"]}}